Navigation Links
Dr. Jonathan White Joins Haemonetics as Head of Research and Development
Date:12/8/2008

BRAINTREE, Mass., Dec. 8 /PRNewswire-FirstCall/ --Haemonetics announced today that Dr. Jonathan White will join the Company as head of Research and Development, Vice President of Haemonetics, effective December 8, 2008. In this role, Dr. White will have global responsibility for leading development of the next generation of products to complement Haemonetics' blood management solutions portfolio.

Brad Nutter, Haemonetics' Chairman and CEO, said, "As the global leader in blood management solutions for our customers, we are continually strengthening our product suite with medical devices, information management platforms, and services for blood collectors and hospitals to reduce costs and improve patient outcomes. Dr. White has an extraordinary portfolio of skills and a diverse background which will strengthen our blood management R&D initiatives. We are pleased to welcome him to Haemonetics."

Prior to joining Haemonetics, Dr. White worked for Pfizer Inc. and spent 10 years in a variety of progressive roles encompassing: strategy and business development, leadership of the information technology function, and building R&D platforms for innovation. He led the integration of the R&D organizations of Pfizer and Warner-Lambert Pharmaceutical Company following Pfizer's acquisition of Warner-Lambert. He also served as Chief Innovation Officer for Pfizer. Prior to this, Dr. White worked for McKinsey & Company as a management consultant, where he worked for 6 years in its global healthcare practice serving a variety of clients (including Pfizer) in Europe, China, Africa and the U.S.

Mr. Nutter added, "Dr. White's global business acumen, medical background, strategic thinking, and innovation skills coupled with his knowledge and experience in information technology and consulting services ideally prepare him to play a key role in Haemonetics' leadership team as we build our vision for Blood Management Solutions."

Dr. White, age 49, completed his education and early work as a physician in the United Kingdom. He is a certified neurosurgeon who has worked in both clinical and academic medical settings. He also holds a Masters in Computer Science from Cambridge University as well as a Masters in Business Administration from INSEAD in France.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
2. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
3. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
4. Ability to cope with stress can increase good cholesterol in older white men, study finds
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
7. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
8. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
9. Older blacks and Latinos still lag whites in controlling diabetes
10. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
11. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively for ... logo with a glitch reveal in just a few clicks of a mouse. Customizable glitch ... each preset. Use these presets to add a uniquely animated logo to any photos or ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion Volume 2 features ... ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. Great for ... and choose from hand-crafted trend-setting designs with smooth animations that will add stylistic ...
(Date:2/17/2017)... Diego, CA (PRWEB) , ... February 17, 2017 ... ... initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively impact ... , “The Board of Trustees has long considered it our duty to seriously ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... NEW YORK , February 17, 2017 ... Composite and the S&P 500 edged lower at the ... its bullish streak above the 20,000 benchmark. Moreover, five ... bearish territories. Taking into consideration yesterday,s market sentiment, Stock-Callers.com ... morning: Smith & Nephew PLC (NYSE: SNN ...
(Date:2/16/2017)... (NYSE: DVA ) today announced results for the ... Net income attributable to DaVita Inc. for the quarter and ... per share and $880 million, or $4.29 per share, respectively. ... for the quarter and year ended December 31, 2016, excluding ... per share, and $789 million, or $3.85 per share, respectively. ...
(Date:2/16/2017)... Scripts (NASDAQ: ESRX ) was recognized today by Fortune ... Health Care: Pharmacy and Other Services category. "Express Scripts ... Companies," said Tim Wentworth , CEO and President, Express Scripts. ... 26,000 employees to make medicine more affordable and accessible for the ... ...
Breaking Medicine Technology: